AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports - Reuters
AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
All Coverage
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOZEVtOEp1OEtIei1taHdqbUpRRzU2WG4zSjh4M2w3cFNnSzA1a3JUQVd3dWU3Q0MwcUtqWm1OeU4wSU9Ja0V4T3IyRDRwaDdIR05HV2ZHbVp5VlFrdElIU0RfRUdrRUNNNXdEeklDdkxWVVpLbklQZ2x4X3QwMUFCRlJ0MVB2QzBWOUFBenQ0bXFUd3otcVo1VWY1VzM2MXl6Qk56aEZTbWtSYXN5RkliQ040TFZBd1R4VlVGb0g1eGZwTW1PUWlWQlgyWQ?oc=5" target="_blank">AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen - Reuters
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen Reuters
October 2, 2026 at 10:57 AMAbbVie joins US government pilot to test drug discount rebates - Reuters
AbbVie joins US government pilot to test drug discount rebates Reuters
October 2, 2026 at 08:53 PMSanofi to pay Regeneron $1 billion upfront in expanded immunology deal - Reuters
Sanofi to pay Regeneron $1 billion upfront in expanded immunology deal Reuters
October 1, 2026 at 05:17 AMAstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up - Reuters
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up Reuters
September 28, 2026 at 10:15 PMBayer to invest $2.2 billion in new US pharma site - Reuters
Bayer to invest $2.2 billion in new US pharma site Reuters
October 2, 2026 at 07:19 PMWalgreens-owner Sycamore nears $9 billion sale of Boots, WSJ reports - reuters.com
Walgreens-owner Sycamore nears $9 billion sale of Boots, WSJ reports reuters.com
September 30, 2026 at 08:14 PM